Tongling Jieya Biotechnology Achieves Operating Revenue of RMB 419 Million in H1 2026-China Absorbent Hygiene Products Expo|China Health Care Products Expo-China International Disposable Paper Expo

INDUSTRY NEWS

China Absorbent Hygiene Products Expo,China Feminine Care Products Exрo

Tongling Jieya Biotechnology Achieves Operating Revenue of RMB 419 Million in H1 2026

Tongling Jieya Biotechnology Co., Ltd. posted operating revenue of approximately RMB 419 million in the first half of 2026, representing a year-on-year increase of 35.07%. Net profit attributable to shareholders of the listed company reached about RMB 41.664 million, up 27.87% year-on-year. Basic earnings per share stood at RMB 0.37, a year-on-year decrease of 7.5%. Among them, wet-wipe products generated operating revenue of approximately RMB 364 million in H1 2026, rising 38.8% from the prior-year period.

Previous：Xianhe Posts Operating Revenue of About RMB 6.304 Billion in H1 2026 Next：Hetai Runjia Realizes Operating Revenue of RMB 93.81 Million in H1 2026